Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

, BLK

BlackRock

$401.61

1.74 (0.44%)

12:04
10/20/18
10/20
12:04
10/20/18
12:04

Khashoggi case puts financial ties to Saudis under strain, Barron's says

The suspected killing of Washington Post columnist Jamal Khashoggi is costing Saudi Arabia most of the big names that it hoped would adorn a conference known as "Davos in the Desert," with JPMorgan (JPM), BlackRock (BLK), Blackstone Group (BX) and Treasury Secretary Steven Mnuchin saying they will not attend the investment initiative, Bill Alpert writes in this week's edition of Barron's. With the crown prince now allowing the kingdom's subjects to enjoy public entertainments, big plans have been announced by the movie exhibitors AMC (AMC) and IMAX (IMAX), as well as the theme-park operator Six Flags (SIX), Barron's points out, adding that exhibitions in Saudi Arabia are already contributing to the bottom line of WWE (WWE). Reference Link

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

BLK

BlackRock

$401.61

1.74 (0.44%)

BX

Blackstone

$34.66

-0.61 (-1.73%)

AMC

AMC Entertainment

$19.81

0.18 (0.92%)

IMAX

Imax

$22.45

-0.11 (-0.49%)

SIX

Six Flags

$66.40

-1.16 (-1.72%)

WWE

WWE

$82.02

-1.49 (-1.78%)

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 14

    Nov

  • 26

    Feb

JPM JPMorgan
$107.92

-0.21 (-0.19%)

10/16/18
JANY
10/16/18
NO CHANGE
JANY
Buy
Janney Montgomery Scott says On Deck's new unit hints at new bank partnerships
After On Deck Capital (ONDK) announced earlier that it has created a new wholly owned subsidiary, ODX, that will provide technology and other services to banks looking to lend online to small businesses, Janney Montgomery Scott analyst John Rowan said he sees this as the logical step before the company announces one or more new bank partnerships. While he thinks the company's lone existing bank partnership, with JPMorgan (JPM), is not a profit center, Rowan believes that the economics could improve as each new bank partner comes on-board and he thinks ODX could eventually become a profit center for On Deck. He maintains a Buy rating on the stock.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $124
BMOC
Market Perform
JPMorgan price target raised to $124 from $118 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $124 after its Q3 earnings beat driven by lower than expected loan loss provision. The analyst notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotherinham also keeps his Market Perform rating on JPMorgan, saying its two-year forward earnings multiple is "only slightly" below its long-term historical average.
10/03/18
BERN
10/03/18
NO CHANGE
BERN
Amazon to be accelerant of disruption coming for healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes disruption is coming for healthcare and that Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst sees a parallel with the fast changes in health insurance which took place in the 90's, when health insurance changed from 90% indemnity to 80% managed care within ten years. Wilkes thinks Amazon is developing a series of business strategies for entering healthcare market segments, namely directly entering online pharmacy, creating a disruptor in the employer healthcare space through its venture with Berkshire (BRK.A) and JPMorgan (JPM), and entering digital consumer healthcare spaces including using Alexa for consumer engagement and behavior modification.
09/25/18
WOLF
09/25/18
INITIATION
Target $140
WOLF
Outperform
JPMorgan initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated JPMorgan with an Outperform and $140 price target.
BLK BlackRock
$401.61

1.74 (0.44%)

10/17/18
ARGS
10/17/18
NO CHANGE
Target $535
ARGS
Buy
BlackRock price target lowered to $535 from $620 at Argus
Argus analyst Stephen Biggar lowered his price target on BlackRock to $535 even though the company beat on Q3 earnings, saying that its revenue grew by "only 2%" and its long-term net inflows of $10.6B were the lightest in 10 quarters. The analyst notes that the industry is undergoing a period of weak inflows, with the institutional segment posting equity index outflows due to "trade tensions, emerging market weakness and a steepening yield curve". Biggar keeps his Buy rating on BlackRock longer term, noting that de-risking will eventually subside as the company continues to deliver above-average operating margins.
10/17/18
DBAB
10/17/18
NO CHANGE
Target $475
DBAB
Buy
BlackRock core revenue growth is slowing, says Deutsche Bank
Deutsche Bank analyst Brian Bedell says that while BlackRock remains the "best franchise" in asset management, its core revenue growth is slowing. He expects this to persist amid a likely slower future pace of organic growth and fee pressure from mix shift toward more appealing lower cost products. The analyst lowered his price target for BlackRock to $475 from $550 following yesterday's Q3 results but keeps a Buy rating on the name.
10/17/18
SBSH
10/17/18
NO CHANGE
Target $500
SBSH
Buy
BlackRock price target lowered to $500 from $550 at Citi
Citi analyst William Katz lowered his price target for BlackRock to $500 saying near-term base fee pressure and elevated macro risk temper his bullish on the shares. However, the analyst left the company's Q3 results confident in its "resilient business model." He believes the core story is intact and keeps a Buy rating on BlackRock.
10/17/18
WELS
10/17/18
NO CHANGE
Target $440
WELS
Market Perform
BlackRock price target lowered to $440 from $510 at Wells Fargo
Wells Fargo analyst Christopher Harris lowered his price target for BlackRock to $440 from $510 after the stock sold off materially likely based on the quarter's revenue, operating income and flow shortfalls and the extent of fee rate degradation. The analyst reiterates a Market Perform rating on the shares.
BX Blackstone
$34.66

-0.61 (-1.73%)

09/24/18
MSCO
09/24/18
NO CHANGE
Target $48
MSCO
Overweight
Blackstone price target raised to $48 from $42 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys said he came away from Blackstone's investor day more positive on the company's superior AUM and fee growth and ability to innovate. Blackstone also said a C-Corp conversion is under active consideration, which is a more positive stance than in it has expressed in the past, Cyprys tells investors. Based on expectations for strong growth in AUM, management fees and performance fee, along with the rising prospects for C-Corp conversion, Cyprys raised his price target on Blackstone shares to $48 from $42 and keeps an Overweight rating on the stock.
09/25/18
ARGS
09/25/18
NO CHANGE
Target $46
ARGS
Buy
Blackstone price target raised to $46 from $39 at Argus
Argus analyst Stephen Biggar raised his price target on Blackstone to $46 and kept his Buy rating after its Investor Day presentation on Friday, citing the company's outlined plans to grow its assets under management to $1T from $439B currently. The analyst states that Blackstone is seeing "sees considerable growth in real estate, private equity, infrastructure, tactical opportunities and credit assets", adding that while the $1T target is "aggressive", it is also achievable, requiring "continuing cooperative economic environment and fundraising efforts". Biggar also anticipates Blackstone's "fee-related earnings component to grow significantly over the next two years" as its flagship funds reach key milestones, helping reduce earnings volatility and yielding "more consistent" dividend payouts.
09/24/18
SBSH
09/24/18
NO CHANGE
Target $47.5
SBSH
Buy
Blackstone price target raised to $47.50 from $43 at Citi
Citi analyst William Katz raised his price target for Blackstone to $47.50 following last week's investor day. The analyst left constructive on the Alternatives sector and impressed by the "multitude of earnings drivers" at Blackstone. He's encouraged by the company's "growing competitive moat and longer-term opportunities" and keeps a Buy rating on the shares.
09/24/18
JMPS
09/24/18
NO CHANGE
Target $43
JMPS
Outperform
Blackstone price target raised to $43 after investor day at JMP Securities
JMP Securities analyst Devin Ryan raised his price target on Blackstone shares to $43 from $39 following the company's investor day, from which he said the primary takeaway was the company's detailed roadmap for growth to $1T+ of AUM over the next eight years from $439B of total assets today. Ryan, who said Blackstone communicated a "clear line of sight" into $2 of fee-related earnings over the longer-term, keeps an Outperform rating on Blackstone shares.
AMC AMC Entertainment
$19.81

0.18 (0.92%)

09/17/18
WEDB
09/17/18
NO CHANGE
Target $25
WEDB
Outperform
AMC could see multiple expansion with more consistent performance, says Wedbush
Wedbush analyst Michael Pachter reiterated an Outperform rating and $25 price target on AMC Entertainment, telling investors in a research note that another few quarters of consistent performance should result in multiple expansion so long as AMC remains committed to meaningfully paying down debt. Pachter expects AMC to trade at the high end of its historical 7-8.5x EV/EBITDA multiple range should it demonstrate consistent earnings power.
09/14/18
MKMP
09/14/18
DOWNGRADE
MKMP
Neutral
AMC Entertainment downgraded to Neutral from Buy at MKM Partners
09/17/18
IMPC
09/17/18
NO CHANGE
Target $23
IMPC
Outperform
AMC buying shares from Wanda a 'major positive,' says Imperial Capital
Imperial Capital analyst David Miller views AMC Entertainment buying back 24M shares from Wanda as a "major positive." The overhang on the stock created by the uncertainty surrounding what Wanda might do has been an issue for over one year now, and so any transaction which decreases that uncertainty may help AMC investors "sleep a little easier," Miller tells investors in a research note. The analyst believes that while the risk is still there for Wanda to :easily dump more shares in the open market," this is unlikely to happen given that private equity firm Silver Lake, the lead sponsor on the transaction, will retain right of first refusal for two years on future transfers of AMC shares. This in effect issues a "rhetorical vote of confidence to the current management team," Miller says. He keeps an Outperform rating on AMC with a $23 price target.
09/14/18
09/14/18
DOWNGRADE
Target $21

Neutral
MKM downgrades AMC Entertainment to Neutral citing deal dilution, valuation
As previously reported, MKM Partners analyst Eric Handler downgraded AMC Entertainment to Neutral from Buy, stating that he believes the increase in the company's already above average net leverage and eventual 6% share dilution from Silver Lake's $600M strategic investment is a cause for concern. It is also hard to argue for the stock's multiple to rise when free cash flow, after dividend payments, is negative or only slightly positive, added Handler. He maintains a $21 fair value estimate on the stock.
IMAX Imax
$22.45

-0.11 (-0.49%)

04/27/18
04/27/18
UPGRADE
Target $28

Buy
Imax upgraded to Buy on strong box office expectations at Benchmark
As previously reported, Benchmark analyst Mike Hickey upgraded Imax to Buy from Hold, saying he expects near-term performance to benefit from a strong box office with potential upside versus the consensus led by ongoing cost controls. He also suspects the company could raise its installation guidance for the year, as they did during the same period last year. Hickey set a $28 price target on Imax shares.
04/27/18
BNCH
04/27/18
UPGRADE
BNCH
Buy
Imax upgraded to Buy from Hold at Benchmark
07/31/18
RILY
07/31/18
NO CHANGE
Target $26
RILY
Buy
B. Riley FBR adds Xperi to Alpha Generator list, removes Imax
B. Riley FBR analyst Eric Wold added Xperi (XPER) to his firm's Alpha Generator list in place of Imax (IMAX). The analyst sees an attractive entry point with Xper shares down 65% over past 18 months. Potential for multiple positive intellectual property licensing catalysts in next 6-12 months should lessen investor concerns, Wold tells investors in a research note. He has a Buy rating on Xperi with a $26 price target.
10/10/18
RILY
10/10/18
NO CHANGE
Target $34
RILY
Buy
Imax shares to move higher as two concerns dissipate, says B. Riley FBR
B. Riley FBR analyst Eric Wold believes Imax shares will benefit from the positive elimination of two major investor concerns, namely a lack of margin growth and China box office declines. He sees China per screens returning to growth just ahead of an "extremely" Imax- and China-friendly film slate in 2019. Further, without any new initiative margin headwinds, the company should return to 40%-plus EBITDA margins in 2019 for first time since 2010, Wold tells investors in a research note. He keeps a Buy rating on Imax with a $34 price target.
SIX Six Flags
$66.40

-1.16 (-1.72%)

07/09/18
07/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GAMESTOP STARTED WITH A BUY: Jefferies analyst Stephanie Wissink started GameStop (GME) with a Buy rating and $18 price target. Her contrarian view on the stock is that under potential new leadership with a well defined vision and execution plan, the stock's valuation, which she feels is "overlooked and overly discounted," could improve. GameStop is higher by 2.5% in midday trading. PIPER SEES CISCO LOSING SECURITY SHARE TO PALO ALTO: Piper Jaffray analyst James Fish says his firm's recent channel survey work across networking and security were weaker than he's seen in past calendar quarters for Cisco Systems (CSCO). Cisco's Security survey results were "especially weak," implying Palo Alto Networks (PANW) is taking market share, the analyst said, although the former remains his top networking pick. He kept an Overweight rating on Cisco shares, which were down almost 1% in midday trading. JEFFERIES DOWNGRADES P&G: Jefferies analyst Kevin Grundy downgraded Procter & Gamble (PG) to Hold from Buy and lowered his price target for the shares to $79 from $83. Slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower, Grundy told investors in a research note titled "Tide Unlikely to Turn: Downgrade to Hold as Bull Thesis Wanes." Grundy said he preferred shares of Church & Dwight (CHD) and Energizer (ENR) for exposure to the Home and Personal Care space. TRADE DESK STARTED WITH A SELL: Pivotal Research analyst Brian Wieser initiated Trade Desk (TTD) with a Sell rating and $58 price target, stating that he believes the company can grow rapidly this year but should then see its growth decelerate. He believes its growth will plateau at a size smaller than Criteo's (CRTO), on which Wieser also initiated coverage this morning with a Buy rating. WELLS FARGO DOWNGRADES TWO THEME PARKS: Wells Fargo analyst Timothy Conder downgraded both SeaWorld (SEAS) and Six Flags (SIX) to Market Perform from Outperform, citing valuation, negative seasonal trading patterns, and weather impact, despite ongoing favorable consumer fundamentals and the key Q3 just starting. SeaWorld is trading down 1.3%, while Six Flags is down 1.7% at midday.
07/20/18
WEDB
07/20/18
DOWNGRADE
WEDB
Neutral
Six Flags downgraded to Neutral from Outperform at Wedbush
07/20/18
WEDB
07/20/18
DOWNGRADE
Target $70
WEDB
Neutral
Six Flags downgraded to Neutral from Outperform at Wedbush
Wedbush analyst James Hardiman downgraded Six Flags (SIX) to Neutral from Outperform and cut his price target on shares to $70 from $76, citing the "potentially negative read-throughs" that recent disappointing results from peer Cedar Fair (FUN) could imply. In a research note to investors, Hardiman says that weather was "not the driver" of Cedar Fair's weakness, but that it could be a headwind for Six Flags in Q2. While there is "a lot to like" about the company's growth initiatives, Hardiman says he is taking a step back for the time being until he is more comfortable with the trajectory of the core park business.
10/04/18
SBSH
10/04/18
NO CHANGE
Target $20
SBSH
Sell
Citi remains bearish on SeaWorld despite upping target to $20
Citi analyst Jason Bazinet raised his price target for SeaWorld Entertainment (SEAS) to $20 from $15 but maintains a Sell rating on the shares. The stock's valuation is "rich on many metrics" after rallying 100% since May, Bazinet tells investors in a research note. He believes the multiple "looks stretched" when compared to peers like Six Flags (SIX) and Cedar Fair (FUN) given light of SeaWorld's higher capital intensity, lower free cash flow, lower dividend yield and higher leverage. Further, Bazinet expects SeaWorld's attendance trends to slow amid tougher comps.
WWE WWE
$82.02

-1.49 (-1.78%)

07/24/18
NEED
07/24/18
NO CHANGE
Target $100
NEED
Buy
WWE price target raised to $100 from $80 at Needham
Needham analyst Laura Martin raised her price target on WWE to $100 and kept her Buy rating, citing the valuation upside coming from "subscriber revenue and linear TV fee growth outside the U.S." The analyst notes that the viewing trend shifts toward the internet "over-the-top" format on connected TVs and smartphones is benefiting the company, as its premium video content targets those devices. Martin adds that with "millions of wrestling fans creating short form content and sharing it with their friends globally", WWE can drive incremental ad revenue from those posts without any additional content costs.
07/27/18
WELS
07/27/18
NO CHANGE
Target $97
WELS
Outperform
WWE price target raised to $97 from $83 at Wells Fargo
Wells Fargo analyst Eric Katz raised his price target for WWE to $97 saying the company continues to reset expectations higher with another beat and raise quarter. WWE delivered strong results again, Katz tells investors in a post-earnings research note. He believes the company continues to find new and highly profitable ways to monetize its content. WWE has one of the best long-term stories in the space, Katz contends. He keeps an Outperform rating on the shares.
08/27/18
SBSH
08/27/18
NO CHANGE
Target $85
SBSH
Neutral
WWE price target raised to $85 from $69 at Citi
Citi analyst Jason Bazinet raised his price target for WWE to $85 saying the company is poised to generate increasing free cash flow for the foreseeable future. The analyst has greater visibility into WWE's free cash flow growth through 2024 following the recent domestic TV licensing renewals. Bazinet, however, ascribes a lower multiple to WWE as Formula One's licensing renewal cycle still lies ahead. He keeps a Neutral rating on the shares.
10/09/18
NEED
10/09/18
NO CHANGE
Target $100
NEED
Buy
WWE EPS view lowered at Needham on higher stock-based comp costs
Needham analyst Laura Martin kept her Buy rating and $100 price target on World Wrestling Entertainment but lowered her expected FY EPS view to 74c from $1.01 previously. The analyst cites the higher than anticipated stock-based compensation costs after WWE stock price nearly tripled year-to-date, along with higher interest expenses from rising rates and elimination of the tax credit. Despite the lower profitability, Martin also raises her FY18 revenue forecast by 3% to $919.7M to reflect the recently announced second event in Saudi Arabia and the higher than estimated eCommerce division sales during the holiday period.

TODAY'S FREE FLY STORIES

13:05
12/13/18
12/13
13:05
12/13/18
13:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

AEGN

Aegion

$17.61

-0.43 (-2.38%)

13:01
12/13/18
12/13
13:01
12/13/18
13:01
Hot Stocks
Aegion names Kenneth Young as controller »

Aegion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$87.49

-1.13 (-1.28%)

13:00
12/13/18
12/13
13:00
12/13/18
13:00
Hot Stocks
AbbVie announces $5B boost to stock repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$29.08

-0.985 (-3.28%)

12:59
12/13/18
12/13
12:59
12/13/18
12:59
Hot Stocks
Health Insurance Innovations boosts repurchase program to $100M from $50M »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HIIQ

Health Insurance Innovations

$29.08

-0.985 (-3.28%)

12:57
12/13/18
12/13
12:57
12/13/18
12:57
Hot Stocks
Health Insurance Innovations announces multistate settlement for $3.4M »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IP

International Paper

$43.38

-0.79 (-1.79%)

12:55
12/13/18
12/13
12:55
12/13/18
12:55
Options
International Paper put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$373.22

6.46 (1.76%)

12:51
12/13/18
12/13
12:51
12/13/18
12:51
Periodicals
Tesla plans to ship 3,000 Model 3's per week to Europe, Electrek says »

Tesla is planning to send…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AJG

Arthur J. Gallagher

$75.09

-0.39 (-0.52%)

12:49
12/13/18
12/13
12:49
12/13/18
12:49
Hot Stocks
Arthur J. Gallagher announces new financial, retirement services practice »

Financial wellbeing is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$21.54

0.75 (3.61%)

12:47
12/13/18
12/13
12:47
12/13/18
12:47
Hot Stocks
Clovis says CHMP grants positive opinion for new indicatin of Rubraca tablets »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$28.44

-1.625 (-5.41%)

12:44
12/13/18
12/13
12:44
12/13/18
12:44
Hot Stocks
Breaking Hot Stocks news story on Health Insurance Innovations »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RTIX

RTI Surgical

$4.37

0.11 (2.58%)

12:39
12/13/18
12/13
12:39
12/13/18
12:39
Hot Stocks
RTI Surgical CFO Jonathon Singer buys 50,000 shares of company stock »

RTI Surgical CFO …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,068.50

-5.16 (-0.48%)

, GOOG

Alphabet

$1,057.90

-5.66 (-0.53%)

12:39
12/13/18
12/13
12:39
12/13/18
12:39
Hot Stocks
YouTube says removed 7.8M videos, 224M comments from July-Sept 2018 »

Google's YouTube…

GOOGL

Alphabet Class A

$1,068.50

-5.16 (-0.48%)

GOOG

Alphabet

$1,057.90

-5.66 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

AMZN

Amazon.com

$1,646.55

-16.85 (-1.01%)

12:38
12/13/18
12/13
12:38
12/13/18
12:38
Periodicals
Instacart ending relationship between Amazon's Whole Foods, Recode reports »

Delivery startup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

IIPR

Innovative Industrial Properties

$52.33

1.77 (3.50%)

, KSHB

KushCo Holdings

$0.00

(0.00%)

12:36
12/13/18
12/13
12:36
12/13/18
12:36
On The Fly
Rising High: Talking with Innovative Industrial Properties CFO, KushCo CEO »

In this edition of…

IIPR

Innovative Industrial Properties

$52.33

1.77 (3.50%)

KSHB

KushCo Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.70

-0.41 (-6.71%)

APHA

Aphria

$5.34

-0.46 (-7.93%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CGC

Canopy Growth

$30.89

-1.12 (-3.50%)

CRON

Cronos Group

$11.31

-0.6 (-5.04%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$0.00

(0.00%)

TLRY

Tilray

$75.78

-8.78 (-10.38%)

KNHBF

ICC International Cannabis

$0.00

(0.00%)

MMNFF

MedMen

$0.00

(0.00%)

ORTFD

Biome Grow

$0.00

(0.00%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

NDVAF

INDIVA

$0.00

(0.00%)

OGRMF

Organigram

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$120.74

-1.19 (-0.98%)

12:35
12/13/18
12/13
12:35
12/13/18
12:35
Hot Stocks
Toyota to recall roughly 133,700 vehicles in two separate recalls »

Toyota announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRY

Berry Petroleum

$10.16

-0.51 (-4.78%)

12:35
12/13/18
12/13
12:35
12/13/18
12:35
Hot Stocks
Berry Petroleum announces $100M share repurchase program »

Berry Petroleum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
12/13/18
12/13
12:35
12/13/18
12:35
General news
Treasury 30-year auction preview: the offering should be ok »

Treasury 30-year auction…

HAS

Hasbro

$84.57

-0.26 (-0.31%)

12:30
12/13/18
12/13
12:30
12/13/18
12:30
Options
July 95 strike call buyer in Hasbro tied to hedge »

July 95 strike call buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
12/13/18
12/13
12:25
12/13/18
12:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

CSTM

Constellium

$8.19

-0.22 (-2.62%)

12:25
12/13/18
12/13
12:25
12/13/18
12:25
Conference/Events
Constellium to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 18

    Dec

SBUX

Starbucks

$66.32

0.22 (0.33%)

12:25
12/13/18
12/13
12:25
12/13/18
12:25
Conference/Events
Starbucks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

BABA

Alibaba

$151.67

0.18 (0.12%)

, YOKU

Youku Tudou

$0.00

(0.00%)

12:23
12/13/18
12/13
12:23
12/13/18
12:23
Hot Stocks
Alibaba's Youku to host highlights, documentary content from NFL »

Youku (YOKU), the Alibaba…

BABA

Alibaba

$151.67

0.18 (0.12%)

YOKU

Youku Tudou

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

FIZZ

National Beverage

$79.84

-4.28 (-5.09%)

, STZ

Constellation Brands

$182.12

-4.58 (-2.45%)

12:21
12/13/18
12/13
12:21
12/13/18
12:21
Conference/Events
UBS beverages analyst to hold an analyst/industry conference call »

Beverages Analyst Sean…

FIZZ

National Beverage

$79.84

-4.28 (-5.09%)

STZ

Constellation Brands

$182.12

-4.58 (-2.45%)

PEP

PepsiCo

$118.01

1.03 (0.88%)

CCE

Coca-Cola European Partners

$0.00

(0.00%)

BFB

Brown-Forman, also tag with BF.A, BF.B

$0.00

(0.00%)

BFA

Brown-Forman, also tag with BF.A, BF.B

$0.00

(0.00%)

BF.B

Brown-Forman, also tag with BFA, BFB

$46.92

0.44 (0.95%)

MNST

Monster Beverage

$53.60

-3.84 (-6.69%)

SAM

Boston Beer

$263.73

-10.35 (-3.78%)

KDP

Keurig Dr Pepper

$26.14

0.03 (0.11%)

TAP

Molson Coors

$63.13

0.12 (0.19%)

KO

Coca-Cola

$49.45

0.25 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 18

    Dec

  • 18

    Dec

  • 15

    Feb

  • 03

    Mar

VRTX

Vertex

$171.99

-3.56 (-2.03%)

12:20
12/13/18
12/13
12:20
12/13/18
12:20
Options
Sudden burst of activity in Vertex Pharma weekly calls »

Sudden burst of activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$7.31

0.59 (8.78%)

, AAPL

Apple

$170.93

1.84 (1.09%)

12:20
12/13/18
12/13
12:20
12/13/18
12:20
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been…

GE

General Electric

$7.31

0.59 (8.78%)

AAPL

Apple

$170.93

1.84 (1.09%)

TSLA

Tesla

$371.13

4.37 (1.19%)

QD

Qudian

$6.47

1.21 (23.00%)

CIEN

Ciena

$34.64

2.505 (7.80%)

LLNW

Limelight Networks

$2.39

-0.81 (-25.31%)

TLRD

Tailored Brands

$14.13

-6.03 (-29.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.